NDC 54092-135
Icatibant
Icatibant
Icatibant is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Takeda Pharmaceuticals America, Inc.. The primary component is Icatibant Acetate.
| Product ID | 54092-135_2a050e37-c5c7-457b-95d1-55988a5d1fc5 |
| NDC | 54092-135 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Icatibant |
| Generic Name | Icatibant |
| Dosage Form | Injection, Solution |
| Route of Administration | SUBCUTANEOUS |
| Marketing Start Date | 2019-07-30 |
| Marketing Category | NDA AUTHORIZED GENERIC / NDA AUTHORIZED GENERIC |
| Application Number | NDA022150 |
| Labeler Name | Takeda Pharmaceuticals America, Inc. |
| Substance Name | ICATIBANT ACETATE |
| Active Ingredient Strength | 30 mg/3mL |
| Pharm Classes | Bradykinin B2 Receptor Antagonist [EPC],Bradykinin B2 Receptor Antagonists [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |